Skip to main content

For the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability.

FOR US HEALTHCARE PROFESSIONALS ONLY

Request a Rep Referral Form
Skip to main content
Referral Form

HCP SUPPORT

Support for getting patients started

Regional Nurse Specialist (RNS)

A United Therapeutics RNS is available to help provide clinical education to providers, your care team and associated hospitals on PH-ILD and TYVASO topics, including:

  • PH-ILD screening and diagnosis
  • PH-ILD disease state
  • Hands-on device training
  • Dosing and titration
  • Multidisciplinary education for offices and hospitals
  • AEs and possible mitigation and management strategies*

Therapy Access Manager (TAM)

TAMs provide education on payer requirements to help facilitate access and support reimbursement needs.

  • Offering resources to facilitate patient access to treatment
  • Supporting reimbursement and access questions for patients starting on therapy
  • Providing education on payer requirements for cases pending a prior authorization or appeal submission

*United Therapeutics does not provide medical advice.

Two simple ways to start a referral

Complete the referral form.

Download the referral form, fill it out with your patient, and submit it by faxing 1-800-380-5294.

ePrescribe through iAssist.

To prescribe electronically, visit iassist.com. Get started by creating a new user account, visiting the Start Now section on your dashboard, and searching for TYVASO or TYVASO DPI.

Supply options

TYVASO DPI: a range of kit options to help patients get started and stay on track

Whether patients are starting, switching, or maintaining their treatment with TYVASO DPI, United Therapeutics offers 3 kits with multiple configurations to help.

TITRATION KIT
MAINTENANCE KITS
INSTITUTIONAL KITS

For new patients titrating to their target maintenance dose. Additional cartridges provided to allow for flexible titration

Monthly refill for patients who are on a stable target maintenance dose

For patients admitted to the hospital who need to either begin or continue their treatment

4-week supply and 5 inhalers

4-week supply and 5 inhalers

4-day supply and 2 inhalers

THIS KIT INCLUDES:
AVAILABLE CONFIGURATIONS

16 mcg cartridges (quantity 112)

32 mcg cartridges (quantity 112)

48 mcg cartridges (quantity 28)

MAINTENANCE KITS
16 mcg cartridges
32 mcg cartridges
48 mcg cartridges
64 mcg cartridges
80 mcg cartridges
96 mcg Combo Kit:
32 and 64 mcg cartridges
112 mcg Combo Kit:
48 and 64 mcg cartridges
128 mcg Combo Kit:
48 and 80 mcg cartridges
INSTITUTIONAL KITS
16 mcg cartridges
32 mcg cartridges
48 mcg cartridges
64 mcg cartridges
80 mcg cartridges
TITRATION KIT
For new patients titrating to their target maintenance dose. Additional cartridges provided to allow for flexible titration

4-week supply and 5 inhalers

THIS KIT INCLUDES:

16 mcg cartridges (quantity 112)

32 mcg cartridges (quantity 112)

48 mcg cartridges (quantity 28)

MAINTENANCE KITS
Monthly refill for patients who are on a stable target maintenance dose

4-week supply and 5 inhalers

INSTITUTIONAL KITS
For patients admitted to the hospital who need to either begin or continue their treatment

4-day supply and 2 inhalers

AVAILABLE CONFIGURATIONS
MAINTENANCE KITS
16 mcg cartridges
32 mcg cartridges
48 mcg cartridges
64 mcg cartridges
80 mcg cartridges
96 mcg Combo Kit:
32 and 64 mcg cartridges
112 mcg Combo Kit:
48 and 64 mcg cartridges
128 mcg Combo Kit:
48 and 80 mcg cartridges
INSTITUTIONAL KITS
16 mcg cartridges
32 mcg cartridges
48 mcg cartridges
64 mcg cartridges
80 mcg cartridges

TYVASO nebulizer: kits to help get started

These kits have the materials you need to initiate or continue therapy with the TYVASO nebulizer.

STARTER KIT

REFILL KIT

INSTITUTIONAL STARTER KIT

For new patients titrating to their target maintenance dose

Monthly refill for patients who are on a stable target maintenance dose

For patients admitted to the hospital who need to begin their treatment

28-ampule carton of TYVASO and 2 TYVASO nebulizer devices

28-ampule carton of TYVASO and accessories

4-ampule carton of TYVASO and 2 TYVASO nebulizer devices

STARTER KIT

For new patients titrating to their target maintenance dose

28-ampule carton of TYVASO and 2 TYVASO nebulizer devices

REFILL KIT

Monthly refill for patients who are on a stable target maintenance dose

28-ampule carton of TYVASO and accessories

INSTITUTIONAL STARTER KIT

For patients admitted to the hospital who need to begin their treatment

4-ampule carton of TYVASO and 2 TYVASO nebulizer devices

If additional medication is needed, 4-packs of medication ampules are available for order separately.

Hospital access

Steps to access the TYVASO DPI Institutional Kits and TYVASO Institutional Starter Kit:

  • Contact the selected Specialty Wholesaler to set up a new wholesale account, which can take a few days to activate, or to place a wholesale purchase order
  • Your order will be shipped directly to the hospital from the Specialty Wholesaler

IMPORTANT: To help avoid extended hospital stays due to time required for outpatient insurance approval, it is important to complete a Referral Form if the patient is going to continue taking TYVASO DPI or TYVASO after discharge.

DOWNLOAD REFERRAL FORM

Wholesale ordering can be done through our contracted Specialty Wholesalers:

ORDERING INFORMATION
TYVASO DPI INSTITUTIONAL KITS
TYVASO DPI Dose
Number of Cartridges
NDC #

16 mcg
16
NDC 66302-716-04

32 mcg
16
NDC 66302-732-04

48 mcg
16
NDC 66302-748-04

64 mcg
16
NDC 66302-764-04

80 mcg
16
NDC 66302-780-04

TYVASO NEBULIZER INSTITUTIONAL STARTER KIT
4-ampule carton of TYVASO (1 foil pouch contains four 2.9-mL ampules; each ampule contains 1.74 mg treprostinil [0.6 mg per mL]) and the TYVASO nebulizer (2 devices) for single-patient use only
NDC 66302-206-04

TYVASO 4-PACK CARTON
1 foil pouch containing four 2.9-mL ampules; each ampule contains 1.74 mg treprostinil (0.6 mg per mL)
NDC 66302-206-03

For hospital staff training needs, consult your local United Therapeutics Representative.

You can reach out to a United Therapeutics Representative for other questions about accessing TYVASO for your patients or your practice

AE=adverse event; DPI=dry powder inhaler; PH-ILD=pulmonary hypertension associated with interstitial lung disease.